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ABSTRACT 
Male infertility is now recognised as a significant factor in couples having 
difficulty conceiving. The impact of maternal age has long been known as a 
limiting factor, however recent research indicates that advancing paternal 
age can also negatively impact on a couple's chances of conception. One 
of the major contributing causes of male infertility has now been linked to 
spermatozoa exposure to reactive oxygen species (ROS). Such exposure 
induces oxidative stress when coupled with reduced total antioxidant 
capacity (TAC). Measures of both ROS and TAC are used as tests of 
oxidative stress status (OSS) which are used together to give further insight 
into male fertility status. Current research has revealed that the level of 
DNA fragmentation increases with age and, due to their composition, the 
sperm plasma membrane, DNA double helix and single stranded DNA are 
highly susceptible to ROS attack. ROS cause high levels of lipid 
peroxidation (LPO) that ultimately damages the plasma membrane and 
interferes with its vital functions. ROS also readily attack the purine and 
pyrimidine bases of DNA resulting in DNA damage. It is hypothesized that 
advancing paternal age will impact negatively of levels of ROS, TAC and 
DNA fragmentation in ageing men. The aim of this study was to determine 
the relationship between ROS, TAC and DNA damage on spermatozoon 
viability in relation to age. 
Ejaculated semen samples from 54 men undergoing infertility assessment 
were collected and divided into men aged ~40 years (n=16) and men aged 
::;;39 years (n=38). Samples were examined for their level of ROS and TAC 
as a possible indication of oxidative stress status. Samples were also 
assessed for DNA fragmentation and damage using TUNEL. 
Statistical analysis consisted of independent t-tests, chi-square tests and 
multivariate logistic regression. Analysis found no significant associations 
between ROS, TAC, TUNEL and age. Significant differences were 
observed between abnormal sperm motility and age (p<0.05; t-test and 
2 
regression analysis) and between abnormal sperm concentration and 
TUNEL (p<0.05; chi-square test and regression analysis). 
The results obtained in this present study did not support the hypothesis 
that there is an association between age, ROS, TAG and TUNEL. Research 
has identified a negative correlation between the effects of ROS and 
reduced TAG and advancing age on male fertility. ROS, either alone or in 
combination with reduced TAG, has also been directly associated with an 
increase in DNA damage. An increase in the incidence of certain childhood 
cancers and disease has been linked to spermatozoon DNA damage. 
Future research should be directed toward exploring the influences of these 
factors in relation to advancing paternal age given the potential benefits 
extend beyond the couple and to any future offspring. 
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1.1 INTRODUCTION 
One in seven couples has difficulty conceiving during their reproductive 
lives with male factor infertility implicated ir-1 between 20-80% of these 
cases (Agarwal et al., 2004; Pirrello et al., 2005; Tremellen, 2008). It has 
been suggested that male subfertility is increasing (Male Infertility, 2005). 
Environmental, physiological and genetic factors have all been associated 
with reduced sperm function and unexplained male factor infertility (Sikka, 
2001 ). The accurate identification of possible factors leading to infertility 
requires vast knowledge of the conditions deemed favourable for normal 
sperm development and function 0 (Sikka, 2001 ). At present it is more 
common for couples to delay parenthood well into their thirties, without 
considering that their fertility status may be reduced to the point where 
assistance is required (Lampic et al., 2006; Sloter, Schmid, Marchetti et al., 
2006; Tough et al., 2006). While the impact of age on female fertility has 
long been realized (Schmid, Eskanazi et al., 2007) only now are we starting 
to investigate male fertility. Advanced paternal age at the time of conception 
has now been associated with a number of diseases such as 
schizophrenia, multiple endocrine neoplasia and achondroplasia as well as 
with decreased semen parameters, chromosomal abnormalities and 
reduced fertility (Baker & Aitken, 2005; Lambert, Masson & Fisch, 2006; 
Plastira, Msaouel, Angelopoulou et al., 2007; Schmid et al., 2007). 
Aetiologies implicated in male infertility include gene mutations, aneuploidy, 
infectious diseases, ejaculatory duct occlusion, varicocoele, radiation, 
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chemotherapy and erectile dysfunction (OIIero et al., 2001; Smith et al., 
2006). Whilst many of these conditions are treatable, there remain cases 
where no immediate identification of the fertility problem can be made. It is 
well documented that older men take longer to produce pregnancy with an 
increasing proportion undergoing treatment (Ng et al., 2004). Recent 
research appears to focus primarily on the effects of reactive oxygen 
species (ROS), antioxidants, DNA damage and age on the fertilizing 
capabilities of human spermatozoa (Ebisch et al., 2007; Plastira et al., 
2007; Tremellen, 2005). 
1.1.1 Spermatozoon Anatomy 
1.1.1.1 The Head 
The anatomy of human sperm is presented in Figure 1. The head of the 
spermatozoon is composed of a tightly condensed and compact nucleus, 
containing DNA, and an acrosomal cap. The spermatozoon nucleus 
undergoes considerable reorganisation during the latter stages of 
spermatogenesis where approximately 85% of nuclear histones are 
replaced with nuclear protamines (Kalthoff, 2001, p.58; Boe~Hansen et al., 
2006). Protamines are proteins containing a high content of positively 
charged amino acids (Oliva, 2006) and provide multiple functions. These 
include the generation of a more condensed paternal genome resulting in a 
more compact and hydrodynamic head, protection of the genome by 
making it largely inaccessible to nucleases or mutagens present in the 
surrounding environment and removal of epigenetic information from the 
paternal genom~ allowing for reprogramming in the oocyte. Also in some 
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unknown manner protamines participate in imprinting of the genome during 
spermatogenesis (Oliva, 2006). 
Another stage in spermatogenesis involves the reduction or 'pinching off' of 
cytoplasm. This results in a mature spermatozoon with a characteristic 
shape containing little cytoplasm. The cytoplasm is a major reservoir of 
cellular defense mechanisms and in the immature spermatozoa aids in 
normal cell maintenance and function. As the majority of the cytoplasm is 
removed mature spermatozoa are left with few cytoplasmic defense 
mechanisms (Ebisch et al., 2007). 
Figure 1 Spermatozoon Anatomy 
Mature spermatozoon 
Head Neck Middle piece 
(Ref: Young & Heath. 2002) 
1.1.1.2 Plasma Membrane 
l'Eill 
Principal piece End piece 
The plasma membrane encases the head and contains a specific 
combination of phospholipids, cholesterol and proteins to ensure its optimal 
functioning (Kalthoff, 2001, p58). In normal intact functional plasma 
membranes the negatively charged membrane phospholipid 
phosphatidylserine (PS) is located on the inner side of the plasma 
membrane. At the onset of membrane disturbance PS is translocated to the 
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outer surface of the plasma membrane (Glander & Schaller, 2000) and is 
considered a marker of reduced sperm function. 
1.1.1.3 The Midpiece 
The midpiece of spermatozoa is rich in mitochondria and strategically 
placed at the base of the tail which utilizes the majority of the ATP 
generated (Kalthoff, 2001, p.58). Mitochondrial activity in the mid piece 
provides the ATP required to power the tail (Martini, 2001, p.1025). As a 
result of this localization the midpiece becomes more fragile and is the 
major target site for damage by reactive oxygen species (ROS; see section 
2). 
1.1.1.4 The Tail 
The tail (also known as the flagellum) consists of a principal and end piece 
and works in a corkscrew motion to allow forward movement. The principal 
piece is composed of an axonemal core surrounded by a fibrous sheath 
and the end piece of axoneme only. The axoneme of the flagellum refers to 
the 9 plus 2 arrangement of microtubules (Kalthoff, 2001, p.28-29). 
1.1.2 Capacitation 
Capacitation refers to a series of structural and functional changes 
occurring in spermatozoa that begins after the removal of stabilizing factors, 
one of which is cholesterol, from seminal plasma and ends when 
spermatozoa are capable of responding to zona pellucida ligands on the 
oocyte by undergoing the acrosome reaction (De Jonge, 2005). Cholesterol 
within seminal plasma appears to impose a regulatory function on 
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capacitation and be a major seminal plasma inhibitor. Investigations have 
revealed that, on transit through the cervical mucous, the sperm plasma 
membrane undergoes further remodeling and loses both cholesterol and 
glycerol-phospholipids (De Jonge, 2005). Hyperactivation seems to occur 
immediately prior to the acrosome reaction and describes an apparent 
change in characteristic sperm motility. There is clear evidence that several 
critical components need to be present for initiation and optimization of 
capacitation (De Jonge, 2005). 
1.1.3 Acrosome Reaction 
Spermatozoa undergo the acrosome reaction in response to the zona 
pellucida, the oocytes extracellular matrix (Herrero, Lamirande & Gagnon, 
2003). Capacitated sperm bind, at their head and equatorial segments 
(Kalthoff, 2001, p.84), by way of a sperm membrane binding site to the ZP3 
glycoprotein receptor on the zona pellucida. This association triggers an 
influx of calcium which amongst other functions causes the completion of 
meiosis II in the oocyte and activates enzymes to accelerate protein 
synthesis (Martini, 2001, p.1 067). Once bound, acrosomal vesicles are 
exocytosed and digest portions of the cumulus, corona radiata and zona 
pellucida. At this point reorganization of the plasma membrane allows the 
fusion of the sperm and oocyte plasma membranes and aids in the 
preclusion of polyspermy (Kalthoff, 2001, p. 85-93). 
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1.2 REACTIVE OXYGEN SPECIES {ROS) 
Reactive oxygen species or oxygen free radicals are highly reactive 
compounds that contain one or more unpaired electrons. Such compounds 
include superoxide anion (02 ·-), hydrogen peroxide (H20 2), peroxyl radicals 
(ROO") and hydroxyl radicals (OH") (Sikka, 2001; Tremellen, 2008; 
Sanocka & Kurpisz, 2004). Tremellen (2008) points out that leukocytes and 
sperm are the two primary sources of free radicals within semen. 
Male germ cells at various stages produce ROS and their production is 
essential at specifically controlled concentrations for normal sperm function 
(Sikka, 2001). Studies have found that there is a negative association 
between ROS concentration and morphology, motility, seminal plasma and 
ejaculate volume, sperm vitality, membrane integrity, DNA fragmentation, 
total antioxidant concentration (TAC) and fertilization rate (Ebisch et al., Gii-
Guzman et al., 2001; 2007; Hammadeh et al., 2006; Lopes et al., 1998). 
Immature spermatozoa show excessive ROS production, which is directly 
associated with QNA damage in mature spermatozoa (Hammadeh et al., 
2006; Moustafa et al., 2004). Both superoxide and the hydroxyl radical 
(OH"), being the most toxic ROS (Sikka, 2001), are mutagenic. ROS 
production is highest in immature spermatocytes and lowest in mature 
spermatozoa and immature germ cells (Gii-Guzman et al., 2001). 
Leukocyte production of ROS in seminal plasma is also of importance as 
they have been reported to produce anywhere from 1 00- to 1 000- fold 
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higher amounts than that of spermatozoa even at capacitation (Moustafa et 
al., 2004; Tremellen, 2008) 
It is becoming increasingly apparent that spermatozoa ROS production is 
significant in the aetiology of infertility. Both ROS produced by leukocytes 
and spermatozoa impose a negative effect on sperm DNA integrity 
however, it is the ROS produced by spermatozoa that is the most 
significant (Tremellen, 2008). This is believed to be a result of the close 
proximity between the ROS production and sperm DNA. Free radicals 
attack the purine and pyrimidine bases and deoxyribose backbone of the 
DNA double helix (Tremellen, 2008). The primary mode of action of ROS is 
believed to be a rapid loss in intracellular ATP resulting in axonemal 
damage and reduced sperm motility. Hydrogen peroxide (H20 2) is the 
primary reactive oxygen species (ROS) to interact with mitochondrial ATP 
generation (Sikka, 2001 ). The inhibition of sperm mitochondrial function in 
semen samples from infertile patients containing high superoxide levels has 
been observed (Sikka, 2001). Interference with plasma membrane function 
via peroxidaHon ofunsaturated fatty acids is believed to be another mode of 
action. Due to the pivotal role of the plasma membrane this interference 
renders the sperm dysfunctional (Donnelly et al., 1999; Ebisch et al., 2007; 
Sikka, 2001; Tavilani et al., 2008). 
ROS are involved in the processes of sperm capacitation, hyperactivation, 
acrosome reaction (Lopes et al., 1998) and fertilization (Agarwal et al., 
2004; Gii-Gulman et al., 2001). Hydrogen peroxide stimulates the 
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acrosome reaction and hyperactivation of sperm and is also important in 
low levels for sperm-oocyte fusion (Tremellen, 2008). Further to this, 
abnormally high ROS production interferes with sperm-zona pellucida 
binding, sperm-oocyte fusion (Appasamy et al., 2007; Tremellen, 2008) and 
the capacity to regulate intracellular calcium levels (Barroso et al., 2000). 
1.2.1 Lipid Peroxidation 
The plasma membrane is rich in polyunsaturated fatty acids (PUFA) and 
therefore susceptible to ROS attack resulting in lipid peroxidation (LPO) 
(Ebisch et al., 2007; Sanocka & Kurpisz, 2004; Sikka, 2001; Tremellen, 
2008). Oocosahexaenoic acid (DHA) is a major PUFA in spermatozoa and 
accounts for as much as 30% of phospholipid bound fatty acid and 73% of 
PUFA (OIIero et al., 2001; Sanocha & Kurpisz, 2004). DHA aids in 
maintaining membrane fluidity and is the main substrate for LPO. The 
amounts of DHA and cholesterol are reduced during spermatogenesis 
which may be an important modification in reducing the susceptibility of 
mature spermatozoa to oxidative damage (OIIero et al., 2001). The 
significance of this appears to be that the optimal level of DHA is retained 
so as to both optimize membrane fluidity and protect against oxidative 
damage (OIIero et al., 2001; Sanocka & Kurpisz, 2004). 
The plasma membrane increases its permeability to electrolytes as a result 
of reduced membrane integrity from LPO. Essential reactions involved in 
LPO are catalysed by the presence of iron and copper ions. Membrane 
damage appears to be the most evident consequence of free radical 
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damage on sperm viability (Donnelly et al., 1999). The two most common 
pathways of LPO are non-enzymatic and enzymatic. Enzymatic LPO is both 
NADPH and ADP dependent (Sikka, 2001 ). 
Lipid peroxidation of PUFA following exposure to oxidative stress (OS) 
results in a notable decline in sperm motility (Hammadeh et al., 2006). 
Vitamin E terminates lipid peroxidation chain reactions and vitamin C acts 
to also prevent oxidative damage to sperm DNA (Ford & Whittington, 1998). 
1.3 ANTIOXIDANTS 
The majority of vital antioxidant defense systems are present in sperm, 
however their effects are limited due to their minimal concentration. As 
sperm have been stripped of vigorous protective mechanisms against 
oxidative agents, spermatozoa are particularly vulnerable to peroxidative 
damage (Smith et al., 1996). 
Antioxidant defense systems consist of both enzymatic and non-enzymatic 
components (Tremellen, 2008). Enzymatic antioxidants include superoxide 
dismutase (SOD), catalase, glutathione peroxidase, and reductase 
(Agarwal et al., 2004; Sikka, 2001; Tremellen, 2008). SOD and catalase 
both inactivate the superoxide anion (02 ·-) and hydrogen peroxide (H202). 
Washed sperm appear to be more susceptible to toxic oxygen metabolites 
indicating a protective effect of seminal plasma on sperm integrity. Studies 
have revealed that semen samples from subfertile men exhibit lower 
antioxidant capacity and value than that of fertile men, confirming an 
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inverse relationship between antioxidant capacity and LPO exists (Smith et 
al., 1996). 
There are many components of the non-enzymatic antioxidant defense 
systems. They include ascorbate (vitamin C), urate, a-tocopherol (vitamin 
E), pyruvate, albumins, 13-carotene, ubiquinol, glutathione, amino acids 
taurine and hypotaurine, carnitine, carotenoids, flavenoids and 
prostasomes (Smith et al., 1996; Tremellen, 2008). These are all found in 
seminal plasma and act as scavengers of free radicals. Vitamin E is a major 
chain breaking antioxidant found in the sperm plasma membrane and 
suppresses LPO in a dose dependent manner. Albumin does not prevent 
LPO, only neutralizes lipid peroxides by being oxidized itself (Twigg et al., 
1998; Tremellen, 2008; Aitken & Krausz, 2001 ). Prostasomes are 
extracellular organelles that are secreted by the prostate with one of their 
functions being fusion with leukocytes in the ejaculate to reduce their 
production of ROS (Tremellen, 2008). Observations also indicate that ROS 
production is dependent on NADPH. Not only does ROS generation by 
NADPH encourage LPO but also results in a marked increase in DNA 
damage. Albumin specifically reacts with peroxyl radicals and aids the 
slowing of peroxidative damage (Agarwal et al., 2004; Tremellen, 2008). At 
certain levels SOD enzymes hasten the removal of superoxide limiting their 
detrimental effects. Several studies have concluded that NADPH may serve 
as a substrate for SOD production in spermatozoa (Twigg et al., 1998). 
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Total antioxidant capacity (TAC) is a measure of oxidative stress status 
(OSS). As antioxidants react with free radicals to neutralize their effect, an 
excessive amount of ROS production diminishes antioxidant capacity 
resulting in oxidative stress (OS). Ford & Whittington (1998) note the TAG 
of seminal plasma is lower in subfertile men as opposed to fertile men. 
Aitken and Krausz (2001) further this by affirming an inverse correlation 
between fertility status and TAG exists. Treatment with antioxidant 
supplementation assists in cases where reduced TAG is the cause however 
antioxidant therapy appears to work within, at present, undefined limits 
(Tarin et al., 1998; Donnelly et al., 1999). At lower concentrations they 
protect against cellular damage and are even necessary for normal 
function, however at higher concentrations antioxidants add to cellular 
attack, dysfunction and pathological states (Sikka, 2001 ). 
1.3.1 Oxidative Stress 
Oxidative stress (OS) is a condition associated with the overproduction of 
ROS induced by oxygen and oxygen derived oxidants (Sikka, 2001 ). It is 
increased by both a rise in ROS production and a reduction of cellular 
antioxidant capacity and is a key player in the aetiology of abnormal sperm 
function through mechanisms involving peroxidative damage to the plasma 
membrane (Twigg et al., 1998). OS is also known to affect the sperm 
genome by causing high frequencies of single and double DNA strand 
breaks (Hammadeh et al., 2006; Twigg et al., 1998). 
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Sperm are extremely susceptible to OS as a result of their capacity to yield 
ROS and the high content of polyunsaturated fatty acids in their plasma 
membrane (Donnelly et al., 1999; Hammadeh et al., 2006; Smith et al., 
1996). Hz02 is a relatively stable ROS that readily crosses plasma and 
nuclear membranes. Peroxide derived ROS readily reacts with transition 
metals such as iron and copper that are abundant in normal biological 
processes. This results in altered signaling and tissue injury repair 
processes, consequently inducing cellular damage from the catalysis of the 
lipid peroxidation cascade (Aitken & Krausz, 2001). Nitric oxide (NO) has 
been shown to regulate several functions in the male reproductive tract and 
at differing concentrations has opposing effects on sperm motility. At lower 
concentrations it is proposed to play a role in sperm hyperactivation but at 
higher concentrations of NO can inhibit sperm motility (Sikka, 2001; 
Herrero, De Lamirande & Gagnon, 2003). 
1.4 DNA DAMAGE 
For the accurate transmission of genetic material it is essential that sperm 
DNA be of highest quality. In the last stages of spermatogenesis the 
nucleus is condensed and the distinctive shape of the sperm head is 
formed. The ability of mature sperm to undergo DNA repair is greatly 
diminished (Boe-Hansen et al., 2006; Donnelly et al., 1999) as is their 
ability to undergo programmed cell death. The long term effect of DNA 
damage is dependent not only on the extent and location of the damage but 
also on the ability of the oocyte or even early embryo to repair the damage 
(Boe-Hansen etal., 2006; Ollero et al., 2001; Plastira, 2007). 
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Immature spermatozoa exhibit increased DNA damage, alterations in 
protamination, chromatin packaging and excessive ROS production. 
Nuclear alterations observed in spermatozoa from infertile patients include 
abnormal chromatin structure, microdeletions, chromosomal 
rearrangements, aneuploidy and DNA strand breaks (Barroso et al., 2000; 
Moustafa et al., 2004). Aitken and Krausz (2001) remark that both 
mutagenic and promutagenic changes in the sperm genome have been 
extensively associated with advancing paternal age. Sperm function and 
infertility are closely linked to DNA damage. It is well established that 
infertile men exhibit increased chromosomal abnormalities (Black et al., 
2000), however the source of such damage is the cause of much 
deliberation. A common supposition is that defective apoptosis may 
account for a remarkable percentage of spermatozoa with DNA damage. 
Both superoxide and OH" are known to induce chromosome deletions, 
dicentrics and sister chromatid exchanges (Donnelly et al., 1999). DNA 
damage has been well linked to poor pregnancy outcome (Lambert, 
Masson & Fisch, 2006). Moustafa et al. (2004) and Aitken and Krausz 
(2001) present several hypotheses to explain the source of DNA damage in 
sperm. Firstly that it may be the result of improper packaging and ligation 
during spermiogenesis secondly, as a result of OS and finally it may be a 
side effect of apoptosis. 
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1.4.1 Apoptosis 
Programmed cell death or apoptosis is essential for tissue remodeling. It is 
a normal process that occurs within somatic cells as well as amongst 
different sub-populations of spermatozoa where it plays a role in regulating 
sperm concentration, release and the elimination of defective spermatozoa 
(Ebisch et al., 2007; Ford, 2001). Abnormal apoptotic processes have been 
related to selected cases of infertility such as oligozoospermia and sperm 
dysfunction. Appasamy et al. (2007) note that OS is a mediator of apoptosis 
aiding in the removal of defective cells. 
The presence of DNA nicks in spermatozoon could be a result of 
incomplete apoptosis. Expression of Fas, a cell surface protein, is higher in 
infertile men than men with normal semen parameters and believed to be 
associated with apoptosis (Moustafa et al., 2004). Fas expression on the 
plasma membrane is increased during the early stages of apoptosis. The 
inefficient removal of such marked cells in the male reproductive tract 
results in their presence in the ejaculate where they amplify ROS exposure 
to mature spermatozoa. In turn this damages both mitochondrial and 
nuclear membranes (Piastira et al., 2007; Schmid, Eskanazi et al., 2007) 
diminishing DNA protection. New diagnostic methods are now revealing 
that advancing paternal age is commonly associated with many autosomal 
dominant disorders such as achondr~plasia, Aperts syndrome (Schmid, 
Eskanazi et al., 2007), Marfan syndrome and osteogenesis imperfecta 
(Lambert, Masson & Fisch, 2006). 
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1.5 MALE FERTILITY AND AGE 
The functioning of all body systems declines with age and all are 
interconnected, a decline in one system will impact another. For example, 
degenerative changes such as a decrease in protein composition and 
reduced water content in the prostate affects the quality of semen produced 
(Lambert, Masson & Fisch, 2006). DNA damage is significantly higher in 
older men as opposed to younger men. The article Male Infertility (2005) 
reported that DNA damage was considerably higher in males aged over 45 
years than all younger age groups, furthermore, it was doubled in over 45s 
when compared to men younger than 30 years of age. 
There have been few studies addressing the fertility of older men while 
controlling for reduced female fertility. This means the results of such 
studies should be interpreted with caution as they may be influenced by 
lowered female fertility rather than be associated with male fertility and 
advancing age. Testosterone production is known to decline with age 
(Lambert, Masson & Fisch, 2006), usually in the sixth decade of life 
(Martini, 2001). This is both a variable and gradual process amongst 
individuals. While sperm production continues there is a reported decline in 
libido and sexual activity (Ng et al., 2004). Slater et al. (2006) notes that, 
unlike women, there is no apparent age threshold in relation to sperm 
motility however there still appears to be a clear relationship between 
advancing paternal age and decreased sperm motility. 
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Results of the study by Ng et al. (2004) showed that the median semen 
volume and total sperm output reduced significantly in older non-infertile 
men (over the age of 50 years). The study also reported that the probability 
of obtaining normal values for ejaculate volume, sperm density and total 
sperm output was also significantly reduced in older men when compared 
with younger men. There was a significant increase in the frequency of 
abnormal sperm morphology and vitality especially involving sperm tail 
defects observed in this study, which may be a possible reflection of the 
complex cellular structural assembly process of the axoneme, resulting in 
increased opportunity for age-dependent induced damage (Ng et al., 2004). 
Much research has been performed examining the role of antioxidants on 
reproduction, however little has been reported specifically on TAG in 
relation to age. When looking at ROS and OS a similar picture emerges 
where, too few studies have incorporated the added variable of age. Slater 
et al. (2006) furthered this by stating that contributions from both the 
environment as well as the individuals age and diet are poorly understood. 
Clearly there is a need for further examination on such topics and is the 
basis for this study. 
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CHAPTER2: 
HYPOTHESIS and AIMS 
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2.1 HYPOTHESIS 
Advancing age is related to increasing oxidative stress and reduced TAG, 
specifically past the age of 40 years. 
2.2 AIMS OF THE STUDY 
• The overall aim of the study is to ascertain the relationship between 
age and human spermatozoon viability. 
• The specific aim of the study is to determine the relationship 
between the effects of ROS, antioxidants and DNA damage on 
human spermatozoon viability in relation to age. 
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CHAPTER 3: 
MATERIALS and METHODS 
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3.1 Ethics Approval 
Written approval for this study was granted by the King Edward Memorial 
Hospital Internal Ethics Committee (EC05-43.1) and by the Edith Cowan 
University Faculty of Computing, Health and Science Ethics Sub-
Committee for the Conduct of Human Research. 
3.2 Semen Collection and Processing 
Excess semen from samples collected for routine semen analyses or 
Assisted Reproductive Technology at Concept Fertility Centre, Subiaco, 
were utilized for this study. In total 54 semen samples were collected and 
used in the study. Samples were collected through masturbation into sterile 
specimen containers. Patient consent for the use of excess semen was 
obtained prior to use (refer to Appendix 1 for Consent Form). 
A preliminary semen analysis was conducted by Concept staff in 
accordance with the World Health Organisation (WHO, 1999) guidelines. 
Parameters examined include whole semen volume, pH, consistency, 
appearance, concentration, motility and morphology. 
Prior to commencement of TUNEL protocol, 5-20JJI of neat sample was 
smeared on a silanized glass microscope slide (Superfrost Plus, Menzel-
Glaser, Braunschweig), air dried and stored until analysis. 
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Sample processing was performed at the Concept Fertility Centre. Sample 
processing prior to commencement of the ROS assay involved 
centrifugation of liquefied semen samples at 300g for 10 minutes in 20m I 
Falcon tubes. Seminal plasma was aliquoted into a separate Falcon tube, 
later to be transferred to a 2ml microcentrifuge tube and frozen at -SOC until 
later required. The pellet was resuspended in PBS, pH 7.4, at a 
concentration of 3x1 06 sperm/mi. Tubes containing seminal plasma were 
transported on ice to Edith Cowan University, Joondalup. Tubes containing 
sperm suspension were transported in a paper bag and kept between 20-
Information was obtained using a semen analysis questionnaire (refer to 
Appendix 2) at the time of collection regarding cigarette smoking and 
antioxidant supplementation. Ten of the men reported smoking and 4 used 
antioxidant supplements. The distribution of these men between the age 
groups was equal and so they were included in the study. 
3.3 ROS assay 
The ROS assay was performed according to the procedure used by Smith 
et al (2006). Briefly, basal levels of ROS were will be measured using a 
chemiluminescence assay with luminal as the probe. 1 O!JI of 5mM stock 
luminal in dimethylsulphoxide (DMSO) (refer to Appendix 3 for reagent 
preparation) was added to 5001-JI of prepared sperm suspension (refer to 
section 3.2). A negative control was prepared by the addition of 1 O!JI of 
luminal to 5001-JI. of PBS. Results were obtained from sample assessment 
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using a luminometer (FLUOstar OPTIMA) and expressed as counted 
photons per minute. Samples were processed in such a way as to maintain 
a similar time frame between centrifugation and luminescence 
measurement. 
3.4 TAC assay 
The Total Antioxidant Status Assay Kit, Cat. No. 615700 (Calbiochem) was 
utilized for performing the TAC assay. An Eppendorf BioPhotometer was 
set at 600nm absorbance and cuvettes (Eppendorf UVette) with a 1 em 
path length used. The sample was thawed for 20 minutes at room 
temperature. Five minutes prior to use the diluted substrate and chromogen 
were equilibrated at 3rC. A Thermomixer Comfort was used to maintain 
temperature throughout the assay. A blank sample was prepared according 
to Table 1 found in manufacturers protocol (refer Appendix 3). After mixing, 
6001-JI of sample was transferred to a cuvette and initial absorbance (Ao) 
read. The sample was transferred back into the microcentrifuge tube before 
2001-11 of diluted substrate was added. It was mixed again, transferred to a 
cuvette and absorbance read at 3 minutes. A standard was prepared (as 
per Table 1 in the manufacturers protocol) and processed obtaining an 
initial measure and one at 3 minutes. Study samples were then processed 
in the same manner as for the blank and standard samples. Antioxidant 
concentration was determined following manufacturer's calculation of 
antioxidant status found in kit user protocol. The following equation was 
used to determine antioxidant levels in each of the samples. 
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Antioxidant Concentration (mM) = 
Where A = absorbance after 3 minutes 
A0 = initial absorbance 
AA=A-Ao 
[Standard](AA Blank- AA Sample) 
(AA Blank- /j.A Standard) 
[Standard] = concentration of standard (roM) 
Two standard and two blank samples were prepared for 15 study samples, 
the average was used in the calculation of the antioxidant concentration in 
relation to those 15 samples. 
3.5 TUNEL assay 
This assay was performed using the ApopTag® Plus Peroxidase In Situ 
Apoptosis Detection Kit, S71 01 (Chemicon International, Australia). Slides 
were fixed with a 3:1 ratio of methanol/acetic acid solution. Slides were then 
washed in phosphate buffered saline (PBS) and permeabilised in PBS-
0.1% Triton X-1 00 solution and washed in PBS. 751-JI Equilibration buffer 
was applied for at least 10 seconds and excess removed before 551JI 
working strength terminal deoxynucleotidyl transferase (TdT) enzyme was 
applied, covered with a plastic coverslip and incubated at 3rC for one 
hour. Following this the slide was incubated in working strength stop/wash 
buffer and washed in 2 changes of PBS. Anti-digoxigenin peroxidase 
conjugate (651JI) was then applied and allowed to incubate at room 
temperature for 30 minutes. Slides were washed in PBS then 751JI 
p~roxidase substrate applied and allowed to develop for 4 minutes. When 
sufficient colouring had occurred the slides were washed in 3 changes of 
dH20 and air dried. Slides were then counterstained using 0.5% (w/v) 
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methyl green and washed in dH20 and air dried before being viewed by 
brightfield microscopy (1 OOOx magnification). Four hundred sperm were 
counted on each slide with DNA damaged sperm being expressed as a 
percentage. Sperm with DNA damage were stained brown and undamaged 
sperm were stained green (Figure 2). Negative controls were prepared 
following the above procedure but reaction buffer was used instead of the 
working strength TdT enzyme. 
'A 
I 
L 
Figure 2: Pictomicrograph of the TUNEL assay Typical field of view for counting DNA damaged 
sperm. 1000x brightfield microscopy. A region of DNA fragmentation can be seen on the sperm 
labeled (A). The blue/green stained sperm (L) shows no signs of DNA damage. (Photograph 
courtesy of Concept Fertility Centre) 
3.6 Statistical Analysis 
Univariate analysis was used to assess differences between ROS, TAC, 
TUNEL and sperm parameters (motility, morphology, age and total sperm 
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concentration). Independent-group t-tests were performed in the 
comparison between categorical and continuous variables while the chi-
square test for relatedness or independence was performed in the 
comparison of two categorical variables. Statistical analyses were 
performed using the student SPSS for Windows version 15. 
Multivariate logistic regression was used for the examination of the 
relationships between outcome variables (total sperm concentration, 
motility, morphology) and the independent variables ROS, TAC, TUNEL 
and age (Appendix 7). An analyses was also performed between age and 
the study factors. Possible interactions among the independent variables 
included in the regression models were tested and statistical significance 
assessed by the Wald Chi-square statistic. The strength of the associations 
between variables statistically significantly associated with outcome 
variables in the logistic regression analyses was quantified by estimated 
·odds ratios and 95% confidence intervals. 
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4.1 Semen Parameters 
Semen parameters from samples used in this study are presented in 
Table1. Age was grouped into :::;39 yrs and ;;::40 yrs, 16 of the 54 subjects 
were ;;::40 yrs age and 38 were :::;39 yrs age. Morphological normality was 
considered to be met when ;;::15% of the sample had normal morphology. 
The cut off for normal motility was ;;::50%, greater than 50% of the sample 
was required to be motile. Total sperm concentration was normal if greater 
than 20 million per mi. These cut offs were based on standards according 
to the World Health Organisation (WHO, 1999). 
Table 1. Semen Variables 
Ejaculate Total Sperm 
Age Volume Concentration Motility Morphology 
(Years) (mL) (millionlmL) (%motile) (%normal) 
:$39 yrs age 32.6 ± 0.6 3.6 ± 0.2 73.7 ± 6.1 62.9 ± 2.1 19.3 ± 1.6 
Range 26-39 1.7-6.6 10-175 35.7-93.1 5-39 
:2:40 yrs age 45.7 ± 1.4 3.8 ± 0.37 79.7 ± 12.4 50.1 ±4.7 20.4 ± 1.4 
Range 40-59 1.6- 7.1 18-214 16.7-78.6 14-26 
Note: Values are the mean ± SEM and the range 
Differences were observed between age groups in relation to mean total 
sperm concentration, ;;::40 yrs exhibiting higher sperm counts (79.7±12.4) 
than :::;39 yrs (73.7±6.1), and motility, individuals :::;39 displaying higher 
motile counts (62.9±2.1) than ;;::40 yrs (50.1±4.7). Conversely, older men 
had lower percentage of motility than the younger group. 
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Table 2. Studv Factors 
ROS 
Age (counted photons 
(Years) per minute) 
S 39 yrs age 32.6 ± 0.6 494.7 ± 151.4 
Range 26-39 4-5342 
;:: 40 yrs age 45.7±1.4 408.8 ± 137.2 
Range 40-59 3.5- 1825 
Note: Values are the mean ± SEM and the range 
TAC 
([AOX] mM) 
2.3 ± 0.14 
1.09-6 
2.1 ± 0.24 
0.21-5 
TUNEL 
(% positive) 
5.9 ± 0.54 
1.35- 13.4 
7.7 ± 0.86 
3.7- 14.2 
4.2 Multivariate logistic Regression Analyses 
4.2.1 Age 
Multivariate analyses between age, ROS, TAG and TUNEL presented no 
statistically significant associations. 
Table 3. Results of Multivariate Logistic Regression Analysis Examining 
the Relationship between Study Factors and ;::40 yrs age 
study factor 
ROS 
TAC 
TUNEL 'normal' 
ref: 'abnormal' 
~oR: OddsTailo 
4.2.1.1 Motility 
OR* 
0.8 
95%C.I. 
0.99- 1.001 
0.35-1.8 
Waid 
Chi-square df p-value 
0.3 
0.3 
0.8 
0.6 
0.6 
0.4 
Statistical significance was observed between motility and age. Analysis 
predicts that the odds of displaying abnormal sperm motility are 5.4 times 
higher for men ;:::40 years of age than for men :539 years. Statistical 
significance was also observed in univariate analysis (Appendix 7) between 
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sperm motility and age (p=0.014), men S39 years age displayed higher 
counts of motility than those ~40 years age. 
Table 4. Results of Multivariate Logistic Regression Analysis Examining 
the Relationship between Abnormal Sperm Motility and Study Factors 
Wald 
study factor OR* 95%C.I. Chi-square df p-value 
ROS 0.99-1.001 0.4 0.6 
TAC 1.7 0.8-3.6 1.7 0.2 
TUNEL 'normal' 
ref: 'abnormal' 3.8 0.7-21 2.4 0.1 
Age 'S39' 
ref: '0!:40' 5.4 1.2-23.5 5 0.03 
*OR: Odds ratio 
4.2.2 Sperm Concentration and Morphology 
A statistically significant association was observed in the sperm 
concentration model with DNA damage as measured using TUNEL 
(presented in Table 5). Regression analyses predicted that for men with 
moderate levels (1 0-14.9%) for DNA fragmentation the odds of having low 
sperm concentration (count <20 mill/ml) is 38.7 times that than for men with 
___ ln§ignificant levels {<10%) forpNA fr'!glllentation. The 95% Cl (2.1-727.2) 
is very wide and lacking precision which is most likely due to small sample 
size. 
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Table 5. Results of Multivariate Logistic Regression Analysis Examining the 
Relationship between Abnormal Sperm Concentration and Study Factors 
Wald 
study factor OR* 95%C.I. Chi-square df p-value 
ROS 1.001 0.9- 1.002 1.9 0.2 
TAC 1.9 0.5- 7.6 0.9 0.3 
TUNEL 'normal' 
ref: 'abnormal' 38.7 2.06-727.2 5.9 0.02 
Age ':539' 
ref: '2:40' 0.5 0.03-7.3 0.3 0.6 
*OR: Odds ratio 
Table 6. Results of Multivariate Logistic Regression Analysis Examining the 
Relationship between Abnormal Sperm Morphology and Study Factors 
study factor 
ROS 
TAC 
TUNEL 'normal' 
ref: 'abnormal' 
Age ':'039' 
ref: '2:40' 
*OR: Odds ratio 
OR* 
1.1 
1.8 
0.4 
95%C.I. 
0.99- 1.001 
0.5-2.8 
0.25- 12.6 
0.04-4.1 
Wa!d 
Chi-square df p-value 
0.001 0.97 
0.09 0.8 
0.3 0.6 
0.6 0.4 
Statistically significant mean difference across groups was observed 
between total sperm concentration and DNA fragmentation, p<0.001 (refer 
to Appendix 7), with men in the ~40 year age group having higher levels of 
DNA fragmentation, 7.7±0.86 as opposed to 5.9±0.54. Analyses conducted 
using multivariate logistic regression for sperm morphology did not reveai 
any significant associations (Tabie 6). 
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4.3 Limitations and Bias 
Given that associations between ROS, TAC, DNA fragmentation and age 
were not observed in this study, it may have been because the statistical 
power was limited due to a small sample size of 54. Green (2005) suggests 
sample size for regression analyses requires a case:predictor ratio of 10:1 
which is also recommended by Peduzzi et al (1996). In wanting to include 4 
predictors and assess interaction terms at the very least 4 x 10 cases would 
have been required (Peduzzi et al, 1996), and if following recommendations 
by Green (1991) then a minimum sample size of 108 would have been 
required to assess associations with 4 predictors. For testing the overall 
model a minimum sample size of at least 84 would have been required. 
This was not possible in the time available for sample collection. 
The study samples may have been biased as a result of the method of 
collection. All samples were excess samples from routine sperm analysis or 
ART. Samples are more likely to exhibit abnormal qualities than samples 
that had been collected randomly from the general population and so could 
be considered non-representative. The study group ~40 years age was 
under -represented. 
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5.1 Discussion 
Male factor infertility is now recognized as a significant factor for couples 
having difficulty conceiving (Agarwal et aL, 2004; Pirrelo et al., 2005; 
Tremellen, 2008), particularly with current trends showing couples are 
delaying parenthood well into their thirties (Collins & Crosignani, 2005; Ng 
et al., 2004). Female fertility has long been established as declining 
markedly with age, particularly by the fourth decade of life (Piastira et al., 
2007; Schmid et al., 2007) and it has now become apparent that male 
fertility declines with advancing age, albeit not as dramatically as in women 
(Slater et al., 2006). There is a growing body of evidence that reactive 
oxygen species, total antioxidant capacity and DNA fragmentation play a 
very significant role in the aetiology of male infertility. Even though current 
research is focusing on the effects of advancing paternal age, few 
associations have been definitively established (Nanassy & Carrell, 2008). 
Older men are expected to display higher levels of DNA fragmentation 
(Aitken & Krausz, 2001) as a result not only of replicative errors but also 
from the added effects of oxidative damage over time. If antioxidant 
defense mechanisms are lacking there is greater exposure of DNA to ROS 
and a greater possibility of ROS induced DNA damage. The study by 
Barroso et al. (2000) demonstrated a positive correlation between the 
generation of ROS and DNA fragmentation. In the present study men ~40 
years exhibited higher levels of DNA fragmentation consistent with previous 
reports. Recently a study by Angelopoulou, Plastira and Msaouel (2007) 
studied the ageing effects on DNA fragmentation. They observed a 
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significant correlation between age and TUNEL positive levels. They 
compared 61 oligoasthenoteratozoospermic (OAT) patients, divided into 
20-34 year olds and 35-50 year olds, to 49 healthy fertile controls with the 
same age group divisions. TUNEL positive results were on average higher 
for both patient groups as opposed to the controls with the average of the 
35-50 year patient group being significantly higher. Plastira et al (2007) 
observed similar findings in their investigation of OAT patients, older 
patients with OAT displaying higher levels of DNA fragmentation as 
assessed by TUNEL assay. 
In the present study the mean value of T AC was lower in the ~40 year age 
group compared with the younger group and unexpectedly the mean value 
of ROS was higher for the ::539 year age group as opposed to the ~40 year 
age group. As Tremellen (2008) notes male factor infertility, regardless of 
age, has been linked with oxidative stress by several studies. It is a 
combination of both an increase in ROS production and a reduction in TAC. 
Moustafa et al. (2004) conducted a study examining the relationship 
between ROS and TAC in a group of patients that were randomly selected 
from attending a male infertility clinic and a group of controls that were 
donors. Moustafa et al. (2004) observed that patients had a significantly 
higher ROS level than donors, however they observed no significant 
difference of TAC between groups. Another study by Gii-Guzman et al. 
(2001) compared ROS and TAC levels in a group of male patients 
undergoing infertility screening and a group of normozoospermic donors. 
Observations found a significantly lower TAC in patients and a lower mean 
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average of ROS levels in donors. Unfortunately these studies did not 
examine the relationship of TAG and ROS with paternal age. The above 
studies by Moustafa et al. (2004) and Gii-Guzman et al. (2001) involved 
only 50 and 48 samples respectively. 
Reductions in ejaculate volume, sperm motility and morphology have been 
noted with advancing age (Nanassy & Carrell, 2008). Data from the present 
study showed an overall reduction in sperm motility in ;:::40 age group 
although no relationship with ejaculate volume, it being or sperm 
morphology was observed. 
Data collected on the samples from smokers showed comparable readings 
of ROS and TUNEL across both groups when compared to those who were 
non-smokers. It should be noted however that the T AC values obtained 
were not a contributing factor of reduced fertility. Values fell either in the 
expected range of 1.3-1.77mM (refer Appendix 4) or higher, indicative of 
high seminal plasma antioxidant concentration. The aim of this present 
study was to investigate the relationship between age and its influences on 
ROS, TAG and DNA fragmentation. The results obtained did not support 
the hypothesis that an interaction exists. However associations at a non-
significant level were observed between age and TAG with statistically 
significant findings between motility and age and between total sperm 
concentration and DNA fragmentation were found. 
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5.2 Future Investigations 
Present research is uncovering areas of significant concern with regard to 
male infertility. Links between DNA fragmentation and advancing age 
resulting in sub fertility have been well documented (Aitken & Krausz, 2001; 
Barroso et al., 2000; Lambert, Masson & Fisch, 2006; Moustafa et al., 
2004). Reactive oxygen species, particularly when associated with 
oxidative stress, have been shown to increase the level of DNA damage 
found in spermatozoa (Barroso et al., 2000; Donnelly et al., 1999; Lambert, 
Masson & Fisch, 2006) and when using standard analyses is not 
necessarily readily identifiable. Furthermore, total antioxidant capacity is 
associated with both ROS and DNA damage (Baker & Aitken, 2005; 
Sanocka & Kurpisz, 2004; Tremellen, 2008) where it only exacerbates the 
problem. Conclusive evidence needs to be established in linking these 
factors to reduced male fertility particularly concerning advancing age with 
the potential range of benefits falling anywhere between higher success 
rates with ART procedures of IVF and ICSI to a reduction in the incidence 
of childhood disorders resulting from germ line aberrations. 
5.3 Conclusion 
Susceptibility of spermatozoa to oxidative stress is intensified by the 
capacity for them to produce ROS themselves. Oxidative stress, resulting 
from excess reactive oxygen species generation and reduced total 
antioxidant capacity, not only appears to disrupt the fertilizing capacity of 
the sperm but also to attack both nuclear and mitochondrial DNA. The 
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ability of an embryo to both repair this damage and survive to term appears 
to be negatively associated with the level of DNA fragmentation in the germ 
line of spermatozoa. Natural protective mechanisms exist to prevent 
spermatozoa with damaged genomes from participating in the fertilization 
process however with the advent of ICSI these barriers can be bypassed 
resulting in a higher incidence of poor pregnancy outcomes and even 
childhood disease. This highlights the importance of further identifying 
significant interactions between age and other factors such as ROS, TAC 
and DNA damage implicated in the aetiology of male factor infertility. 
Benefits of this approach wol.lld enable a more individual diagnosis and 
treatment and have the potential to reduce the transmission of childhood 
diseases at the genomic level. 
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7.1 Appendix 1 
Consent Form 
BACKGROUND 
Concept Fertility Centre would like to use some of your sperm for a research 
project. Normally, only a portion of your sperm is used for a semen analysis or 
ART preparation and the remainder is discarded. We would like to use this 
surplus sperm to study the effects of age on sperm quality. The causes of male 
infertility include genetic problems, chromosome abnormalities, infectious 
diseases, blockages, radiation, chemotherapy and erectile dysfunction. It is well 
documented that older men take longer to produce pregnancy with an increasing 
proportion undergoing assisted reproduction. Recent research has focused on the 
effects of oxidative stress on human sperm quality. Normal sperm production 
requires a balance between reactive oxygen species and antioxidants. 
Imbalances can cause oxidative stress to occur which can have a significant effect 
on normal human sperm function. This research will provide us with valuable 
information that will increase our knowledge of the factors that effect sperm 
function and may therefore benefit couples with male factor infertility. Your sample 
will not be identifiable in this research. 
1. ................................................................................................. have 
(Given Names) (Surname) 
• read the information above explaining the study entitled "The effects of 
age on human sperm oxidative stress" 
I have read and understood the information given to me. Any questions I 
have asked have been answered to my satisfaction. I agree to allow my 
sperm to be used for this research. 
• I agree that research data gathered from the results of this study may be 
published, provided that names are not used. 
• I am aware that I may withdraw this consent at any time, in writing to the 
Scientific Director. 
If you have any complaints regarding the conduct of this study please refer them to 
Dr Geoff Masters, Director of Clinical Services, who can be contacted on 
9340 8222. 
Dated ................... day of ..................... 20 ....... . 
Signature ............................................. . 
I, ..................................... have explained the above to the signatory who has 
(Investigators full name) 
stated that he understood the same. Signature ...................................... . 
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7.2 Appendix 2 
Semen Analysis Questionnaire 
Please take a few minutes to complete these questions. Your answers will help us 
interpret your semen analysis results. 
1. Is the sample jar labeled with YOUR name and date of birth? 
2. 
3. 
4. 
Please circle the correct answer Yes No 
What time did ejaculation occur? 
Did you collect the whole ejaculate? 
Please circle the correct answer 
If no -what portion was missed 
end 
Yes 
first 
How many days has it been since your last ejaculation? 
No 
middle 
5. Have you suffered from any illness in the last 3 months that raised your 
body temperature? 
Please circle the correct answer Yes No 
Comments: ............................................................................... . 
6. Have you taken any medications during the last 3 months? 
Please circle the correct answer Yes No 
Comments: ............................................................................... . 
7. Have you taken any antioxidant dietary supplementation during the last 3 
months? 
Please circle the correct answer Yes No 
If yes please indicate the type and dosage .................................... . 
8. Have you smoked cigarettes during the last 3 months? 
Please circle the correct answer Yes No 
If yes please indicate the number per day ...................................... . 
Name: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Signature: .................................... . 
*·Please place the completed questionnaire in the paper bag with your 
sample jar and take to the collection cupboard.* 
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7.3 Appendix 3 
ROS Assay Reagent Preparation 
Dimethylsulphoxide (DMSO) Fw: 78.13 
Luminol Fw: 177.16 
1. Weigh out 0.468g ofLuminol. 
2. Add 1.3ml ofDMSO to produce a 2M stock Luminol in DMSO solution. 
3. Aliquot 25 J.Ll of stock luminol in DMSO into a sterile 2ml microcentrifuge. 
4. Add 975J.Ll ofDMSO to produce a 5mM working strength Luminol in 
DMSO solution. 
5. DMSO was stored wrapped in aluminium foil due to its light sensitivity. 
6. Stock and working strength solution was made freshly daily. 
56 
7.4 Appendix 4 
TAC Kit User Protocol (Calbiochem) 
Calbiochem® 
User Protocol 615700 Rev. 20-July-06 JSW 
Total Antioxidant Status Assay Kit 
Cat. No. 615700 
Visit our Interactive Pathways rr.t at 
www.calbiochem.com/pathways 
Note that this user protocol is not lot-specific and is representative of the current 
specifications for this product. Please consult the vial label and the certificate of analysis 
for information on specific lots. Also note that shipping conditions may differ from storage 
conditions. Full details are available at www.calbiochem.com. 
Size 
1 kit 
Form 
50 Tests. 
Format 
Cuvette 
Detection Method 
Colorimetric 
Storage 
Upon arrival store the entire kit contents at 4°C. Note: The concentration of the 
standard is lot-specific. Please refer to the vial label for lot-specific concentration. 
Intended Use 
The Calbiochem® Total Antioxidant Status Assay Kit is designed to assay antioxidant 
levels in serum or plasma samples. Additionally, the assay may be used to measure the 
antioxidant potential of (suitably solubilized) food and drug samples. 
Background 
Free radicals are highly reactive molecules generated by the biochemical redox reactions 
that occur as part of normal cell metabolism, and by exposure to environmental factors 
such as UV light, cigarette smoke, environmental pollutants and gamma radiation . Once 
formed , free radicals attack cell structures in the body. As a result, free radicals have been 
implicated in numerous diseases, including cancer, atherosclerosis, rheumatoid arthritis, 
diabetes, liver damage, and central nervous system disorders. 
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Principle of the Assay 
The Total Antioxidant Status Kit is dependent on antioxidants in the sample inhibiting the 
oxidation of ABTS™ (2,2'-Azino-di-[3-ethylbenz-thiazoline sulphonate]) substrate to 
ABTS™•+ product by metmyoglobin (a peroxidase). The amount of ABTS™•+ product can 
be monitored by reading the absorbance at 600 nm. Under the reaction conditions used, 
the antioxidants in the sample cause suppression of the absorbance at 600 nm to a degree 
that is proportional to their concentration. 
Figure 1: Principle of the Assay 
HX-Fe 3+ + 
metmyoglobin 
l 
.... 
· X-[Fe 4+ =0] + ABTS 
ferrylmyoglobin 
+Antioxidants/ 
Reaction inhib~ed ' 
less A8TS .+ 
produced 
Materials Provided 
~Antioxidants 
ABTS . ++ HX-Fe 3+ 
(Read at 600 nm) 
• Buffer: 1 bottle, 100 ml, Phosphate Buffered Saline 
• Chromogen: 5 vials, 10 ml each, Metmyoglobin and ABTS™ 
• Substrate: 2 vials, 5 ml each, stabilized HzOz 
• Standard: 5 vials, 1 ml each, 6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid* 
*The concentration of the standard is lot specific. Please consult the vial label for 
the concentration. 
Materials Required but not Provided 
• Spectrophotometer or automated analyzer capable of measuring absorbance at 600 nm. 
A temperature controlled cuvette holder is highly recommended. 
• Cuvettes with 1-cm path length 
Precautions and Recommendations 
• AI! pipettes should be thoroughly cleaned before use. Water used in the assay must be 
as pure as possible, the minimum standard being double-deionized water. 
• Ensure that all pipettes have been accurately calibrated and are dispensing the correct 
volume. 
• Ensure that all glassware and disposables are free from contamination, especially from 
hypochlorite and detergents. 
• Check the temperature of the equipment being used for incubation of the samples. 
• Time the reaction carefully. The absorbance changes very rapidly, and any delay in 
taking the reading can lead to a substantial error. 
• Ensure that there has been no loss of standard material upon opening the vial. The 
standard is supplied in lyophilized form, and the vials are, therefore, under vacuum. The 
stopper must be removed slowly to allow air to enter the vial gradually; otherwise there is a 
risk that material will be lost. In addition, before the stopper is fully removed, the bottle 
should be sharply tapped on the bench several times to dislodge any material adhering to 
the stopper. The stopper should then be removed and placed flat side down on the bench 
while the appropriate volume is dispensed into the vial for reconstitution. The stopper 
should then, be replaced and the contents mixed, ensuring that the liquid comes into 
contact with the stopper, so that any material adhering to the stopper is dissolved. 
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Reagent Preparation 
• Chromogen: Add 10 ml Buffer to each vial of Chromogen needed for the assay (10 tests 
per vial). After reconstitution, the Chromogen is stable for 2 days at 4°C or 8 h at room 
temperature. 
• Substrate: Dilute each vial of Substrate needed for the assay by adding 7.5 ml Buffer. 
After dilution, the substrate is stable for 24 hat 4°C. NOTE: Some automated methods do 
not require substrate dilution. 
• Standard: Add 1 ml distilled water to each vial of Standard needed for the assay. After 
reconstitution, the Standard is stable for 2 days at 4°C or 1 month at -20°C. 
Detailed Protocol 
1. Zero the spectrophotometer at 600 nm against air and set temperature to 3rC. 
Equilibrate the diluted Substrate and Chromogen at 3rC for 5 min just prior to use. NOTE: 
It is advisable to equilibrate only the amount of each reagent necessary for the assays to 
be performed. A temperature of 3rC must be maintained throughout the assay. 
2. Add the following to a cuvette: 
Table 1: Addition of Reagents 
Blank STANDARD SAMPLE 
ddH20 20 
Standard 20 
Sample 20 
Chromogen lml lml lml 
3. Mix well and read the initial absorbance {Ao) 
4. Add 200 IJI diluted Substrate to each cuvette. Mix and start the timer simultaneously. 
5. Read the absorbance after exactly 3 min (A) 
Calculations 
Calculation of Total Antioxidant Status 
The antioxidant concentration of the Standard is used to calculate the antioxidant levels in 
the samples. 
1. Determine the ll.A for the samples, standard, and blank. ll.A = A - Ao 
2. Calculate the concentration of antioxidants in the sample using the formula below: 
Figure 2: Antioxidant Concentration Formula 
Antioxidant Con•:::enlration (mM) == [Standard] (I:!. A Blank -!:.A Sample) 
•:/).A Blank -l:!.A Standard:• 
NOTE: If the antioxidant concentration is greater than 2.5 mM dilute the sample with 0.9% 
NaCI andre-assay. Typical antioxidant levels in normal human plasma are 1.30-1.77 mM. 
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Sensitivity 
Typically serum or plasma samples of 20 1-11 are sufficient when using the manual 
method. Samples of 5 IJI are typically sufficient when using an automated 
analyzer. The assay is linear for antioxidant levels less than 2.5 mM. 
Assay Range 
0-25 nmol/1 0 IJI plasma 
Precision 
Intra-assay coefficient of variation= 1.2% (mean= 1.37 mM; n = 20) 
Inter-assay coefficient of variation = 2.4% (mean = 1.35 mM; n = 18). 
Toxicity 
MSDS available upon request. 
References 
Miller, N.J., et al. 1993. Clin. Science 84,407. 
Trademarks 
Calbiochem® is a registered trademark of EMD Biosciences, Inc. 
ABTS™ is a trademark of Roche Diagnostics 
Prices and availability are subject to change. ©Copyright 2006 EMB Biosciences, Inc., an affiliate of Merck KgaA, Darmstadt, 
Germany. All rights reserved. Each product is sold with a limited warranty, which is provided with each purchase. Each product is 
intended to be used for research purposes only. It is not to be used for drug or diagnostic purposes, nor is it intended for human 
use. EMD Biosciences products may not be resold, modified for resale, or used to manufacture commercial products without 
written approval of EMD Biosciences. 
USA and Canada 
Tel (800) 628-8470 
t?chnicai((:DcalbiocheJn.cq 
m 
Germany 
Freephone 0800 100 3496 
techservice@merckbiosciences. 
de 
United Kingdom and Ireland 
UK Freephone 0800 622935 
Ireland Toll Free 1800 409445 
techservice@merckbiosciences.co 
.uk 
All Other Countries 
Contact Your Local 
Distributor 
www.calbiochem.com 
technical@calbiochem.co 
m 
A Brand of EMD Biosciences, Inc., an Affiliate of Merck KGaA, Darmstadt, Germany 
www.calbiochem.com 
FOR RESEARCH USE ONLY. NOT FOR HUMAN OR DIAGNOSTIC USE. 
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7.5 Appendix 5 
Protocol for TUNEL Assay using Apoptag kit and Grading 
System 
DNA Fragmentation in Sperm using Apoptag kit 
Making slides for DNA fragmentation staining 
1. Etch a circle (approx 25mm diameter) on the back of 2 Superfrost Plus slides with a 
diamond pen. 1 of the slides will be used for staining and the 2nd a spare, unless 
used as a negative. 
2. Write the patients identification number and date in pencil on the front of the slide. 
3. Smear the appropriate volume of semen (see below) with the side of a pipette tip 
onto the front of the slide within the circle. 
For sperm counts > 40 mill/ml use 5~1 
For sperm counts 10-40 mill/ml use 1 0~1 
For sperm counts 5-10 mill/ml use 20~1 
For sperm counts < 5 mill/ml perform a spin direct on 1-2 ml of semen and 
use 20~1 
4. Allow slides to dry. 
Staining Slides 
1. Remove 2 slides per patient from the slide box and place in a coplin jar containing 
40 ml methanol/acetic acid (3:1 ratio) for 5 minutes at room temp. 
2. Wash in PBS for 5 mins. 
3. Permeabilise cells by incubating in PBS-0.1% Triton X-1 00 for 5 mins. 
4. Wash in PBS 2 times for 5 mins. Remove equilibration buffer, Reaction buffer and 
Stop/Wash buffer concentrate from freezer. Remove TdT enzyme from freezer just 
prior to use. 
5. Apply equilibration buffer to slides (75~1/5cm2) and incubate at room temp for at 
least 10 seconds. 
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While this is incubating make up working strength TdT enzyme by adding 77~1 
Reaction buffer to 33~1 TdT enzyme (enough for 2 slides). 
6. Blot excess equilibration buffer off the slide and apply working strength TdT enzyme 
(55~1/slide) and cover with a plastic coverslip .. 
7. Place in 3rC incubator for 1 hour. During this incubation make up the Stop/Wash 
buffer by adding 1 ml concentrate to 34m I of dH20 in a coplin jar. 
8. Remove coverslips carefully from slides and incubate in Stop/Wash buffer for 10 
mins. 
9. Wash slides in 2 changes of PBS for 5 minutes each in a coplin jar. 
10. Blot off excess liquid and apply room temperature Anti-Digoxigenin Peroxidase 
conjugate (65~1/5cm2). Incubate in a humidified chamber at room temp for 30 mins. 
11. Wash slides in 2 changes of PBS for 5 mins each in a coplin jar. Make up 
Peroxidase substrate by adding 147~1 DAB dilution buffer to 3~1 DAB substrate for 
every 2 slides. WARNING! DAB is a carcinogen. Handle with gloves and dispose of 
all waste into yellow biohazard bags!! 
12. Stain in substrate (75~1/slide) for 4 minutes at room temp, stopping reaction by 
washing in 3 changes of dH20 at room temp. Airdry slides. 
13. Counterstain slides in Methyl Green (0.5%) solution for 10 mins, followed by 
washing in 2 changes of dH20 (3 quick dips each). 
14. Airdry slides before viewing under microscope (100x oil immersion lens). 
15. Count at least 400 sperm per slide and record results. 
Sperm DNA Fragmentation grading 
Less than 10% : Insignificant level 
10-14.9%: Moderate level 
15 - 19.9% : Significant level 
More than 20% : Severe level 
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7.6 Appendix 6 
TUNEL Assay Reagent Preparation 
10X Phosphate Buffered Saline, pH 7.4 (PBS) 
1. Dissolve 55g of NazHP04, 13.5g of NaHzP04 and 117g of NaCI in 
800ml of dH20. 
2. Adjust pH to 7.4 using NaOH or HCI. 
3. Fill to a final volume of 1 L using dHzO. 
PBS-0.1% Triton X-1 00 
Mix 1 ml of Triton X-1 00 concentrate to 99ml of PBS, pH 7 .4. Store at 4 oc 
for up to 1 month. 
Working Strength TdT Enzyme 
331JI of TdT enzyme was added to 771-11 of Reaction buffer. Quantity 
sufficient for the treatment of two 5cm2 slides. 
Both reagents are components of the Apoptag® Plus Peroxidase In Situ 
Apoptosis Detection Kit, S71 01. 
Working Strength Stop/Wash buffer 
1 ml of Stop/Wash concentrate was mixed with 34ml of dH20. Quantity 
sufficient to treat 5 slides in a coplin jar. 
Stop/Wash buffer comes as a component of the Apoptag® Plus Peroxidase 
In Situ Apoptosis Detection Kit, S71 01. 
Peroxidase Substrate 
Mix 31JI of 50X DAB substrate with 1471JI of 1X DAB dilution buffer. Quantity 
sufficient to treat two 5cm2 slides. 
Both reagents are components of the Apoptag® Plus Peroxidase In Situ 
Apoptosis Detection Kit, S71 01. 
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0.5% Methyl Green Stain 
1. Dissolve 1.36g of Sodium Acetate (C2H302Na·3H20) in 80ml dH20. 
Adjust pH to 4 using acetic acid and make up to 1 OOml using dH20 
to produce a 0.1 M Sodium acetate solution. 
2. Dissolve 0.5g of Methyl green (crystal violet free, Sigma-Aldrich, 
M8884) in 100ml Sodium Acetate solution. 
3. Filter through either a 0.45J.Jm or 0.2J.Jm filter. 
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7.7 Appendix 7 
Results Univariate Models 
Table 1 Univariate Analvses for Total Soerm Count 
Total Sperm Count Total Sperm Count Normal 
Abnormal 
Study variables % 
ROS 7.4a 
TAC 7.58 
Tunel: normal 2.3° 
abnormal 
33.3f 
Age category: ::; 39 7.91 
years 6.3d 
2:40 
years 
a 0 c a e I 
n sample number of analys1s =4 =50 =49 =1 =43 =3 9=6 =35 =15 
* T test for mean difference across groups 
** Chi-squared test for association 
Table 2. Univanate A f s na1vses or ioerm M h I oro1 o o lV 
% 
92.6° 
92.5c 
97.7e 
66.79 
92.1n 
93.8i 
Sperm Morphology Sperm Morphology Normal 
Abnormal 
Study variables % (n) 
ROS 21.28 
TAC 21.28 
Tunel: 20c 
normal 28.6d 
abnormal 
Age category: ::; 39 24 
years 12.5h 
2:40 
years 
a D c .a e g 
n sample number of analysis =7 =26 =5 =2 =20 =6 =19 =1 
• T test for mean difference across groups 
•• Chi-squared test for association 
T bl 3 U a e t A mvana e na•vses f s or ;perm M tTt 0 I l V 
% (n) 
78.8b 
78.8b 
80e 
71.4c 
769 
87.58 
Sperm Motility Abnormal Sperm Motility 
Study variables % (n) 
ROS 12.28 
TAC 22.68 
Tune!: normal 18.2u 
abnormal 
44.4f 
Age category: s 39 13.29 
years 43.8i 
2:40 
years 
a 
-
D c a e g I J n sample number of analysis -12 =42 =41 =8 =36 =4 =5 =33 =7 =9 
• T test for mean difference across groups 
•• Chi-squared test for association 
% (n} 
77.8° 
77.4c 
81.89 
55.69 
86.8n 
56.3j 
Normal 
Test for 
association 
p-value 
0.119* 
0.975* 
0.001** 
0.833** 
Test for 
association 
p-value 
0.958* 
I 0.995* 
0.628** 
0.489** 
Test for 
association 
p-value 
0.690* 
0.610* 
0.086** 
0.014** 
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Table 4. Univariate Analvses for Aae 
:!5 39 years 
Study variables o/o (n) 
ROS 70.4a 
TAC 69.8c 
Tunel: normal 72.7a 
abnormal 
55.6f 
a .D c .a e g 
n sample number of analysis =38 =16 =37 =32 =12 =5 =4 
• T test for mean difference across groups 
•• Chi-squared test for association 
Test for 
~ 40 years association 
o/o (n) p-value 
29.6° 0.733* 
30.2° 0.416* 
27.3e 0.307** 
44.49 
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